BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30282066)

  • 1. Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.
    Liu L; Wang H; Cui J; Zhang Q; Zhang W; Xu W; Lu H; Liu S; Shen S; Fang F; Li L; Yang W; Zhuang Z; Li J
    Cell Physiol Biochem; 2018; 50(1):317-331. PubMed ID: 30282066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.
    Chang KE; Wei BR; Madigan JP; Hall MD; Simpson RM; Zhuang Z; Gottesman MM
    Mol Cancer Ther; 2015 Jan; 14(1):90-100. PubMed ID: 25376608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment.
    Zhang C; Hong CS; Hu X; Yang C; Wang H; Zhu D; Moon S; Dmitriev P; Lu J; Chiang J; Zhuang Z; Zhou Y
    Cell Cycle; 2015; 14(13):2100-8. PubMed ID: 25942376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
    Ho WS; Feldman MJ; Maric D; Amable L; Hall MD; Feldman GM; Ray-Chaudhury A; Lizak MJ; Vera JC; Robison RA; Zhuang Z; Heiss JD
    Oncotarget; 2016 Mar; 7(11):12447-63. PubMed ID: 26799670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.
    Hao S; Song H; Zhang W; Seldomridge A; Jung J; Giles AJ; Hutchinson MK; Cao X; Colwell N; Lita A; Larion M; Maric D; Abu-Asab M; Quezado M; Kramp T; Camphausen K; Zhuang Z; Gilbert MR; Park DM
    Neuro Oncol; 2018 May; 20(6):799-809. PubMed ID: 29294092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential.
    Hong CS; Ho W; Zhang C; Yang C; Elder JB; Zhuang Z
    Cancer Biol Ther; 2015; 16(6):821-33. PubMed ID: 25897893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma.
    Gordon IK; Lu J; Graves CA; Huntoon K; Frerich JM; Hanson RH; Wang X; Hong CS; Ho W; Feldman MJ; Ikejiri B; Bisht K; Chen XS; Tandle A; Yang C; Arscott WT; Ye D; Heiss JD; Lonser RR; Camphausen K; Zhuang Z
    Mol Cancer Ther; 2015 Jul; 14(7):1540-1547. PubMed ID: 25939762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation.
    Gao S; Shan L; Zhang M; Wang Y; Zhan X; Yin Y; Jiang Z; Tao X; Li X; Ye M; Liu Y
    Cell Oncol (Dordr); 2022 Dec; 45(6):1203-1215. PubMed ID: 36136269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anticancer activity of a protein phosphatase 2A inhibitor on chemotherapy and radiation in head and neck squamous cell carcinoma.
    Zhu DW; Yuan YX; Qiao JK; Yu C; Yang X; Wang LZ; Zhang ZY; Zhong LP
    Cancer Lett; 2015 Jan; 356(2 Pt B):773-80. PubMed ID: 25449438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
    Ho WS; Sizdahkhani S; Hao S; Song H; Seldomridge A; Tandle A; Maric D; Kramp T; Lu R; Heiss JD; Camphausen K; Gilbert MR; Zhuang Z; Park DM
    Cancer Lett; 2018 Feb; 415():217-226. PubMed ID: 29199006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
    Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
    Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
    Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
    Mirzapoiazova T; Xiao G; Mambetsariev B; Nasser MW; Miaou E; Singhal SS; Srivastava S; Mambetsariev I; Nelson MS; Nam A; Behal A; Arvanitis LD; Atri P; Muschen M; Tissot FLH; Miser J; Kovach JS; Sattler M; Batra SK; Kulkarni P; Salgia R
    Mol Cancer Ther; 2021 Oct; 20(10):1820-1835. PubMed ID: 34253596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression.
    Dung TD; Day CH; Binh TV; Lin CH; Hsu HH; Su CC; Lin YM; Tsai FJ; Kuo WW; Chen LM; Huang CY
    Food Chem Toxicol; 2012 May; 50(5):1802-10. PubMed ID: 22289577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
    Zhao L; Li R; Gan YH
    Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.
    Ho WS; Wang H; Maggio D; Kovach JS; Zhang Q; Song Q; Marincola FM; Heiss JD; Gilbert MR; Lu R; Zhuang Z
    Nat Commun; 2018 May; 9(1):2126. PubMed ID: 29844427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.
    Otani Y; Sur HP; Rachaiah G; Namagiri S; Chowdhury A; Lewis CT; Shimizu T; Gangaplara A; Wang X; Vézina A; Maric D; Jackson S; Yan Y; Zhengping Z; Ray-Chaudhury A; Kumar S; Ballester LY; Chittiboina P; Yoo JY; Heiss J; Kaur B; Banasavadi-Siddegowda YK
    Neuro Oncol; 2021 Sep; 23(9):1481-1493. PubMed ID: 33556161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LB-100 sensitizes hepatocellular carcinoma cells to the effects of sorafenib during hypoxia by activation of Smad3 phosphorylation.
    Fu QH; Zhang Q; Zhang JY; Sun X; Lou Y; Li GG; Chen ZL; Bai XL; Liang TB
    Tumour Biol; 2016 Jun; 37(6):7277-86. PubMed ID: 26666823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT.
    Zhou HH; Chen L; Liang HF; Li GZ; Zhang BX; Chen XP
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.